Efficacy of testosterone replacement treatment for patients with symptoms of late-onset hypogonadism based on real-world patient satisfaction-Reference-Cited by-同舟云学术

Efficacy of testosterone replacement treatment for patients with symptoms of late-onset hypogonadism based on real-world patient satisfaction

Published:2023 Issue:9 Volume:70 Page:883-890
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Ishikawa Keisuke¹,Tsujimura Akira¹,Miyoshi Miho¹,Miyoshi Yuto¹,Ogasa Taiki¹,Hiramatsu Ippei²,Uesaka Yuka¹,Nozaki Taiji¹,Shirai Masato¹,Kobayashi Kazuhiro³,Horie Shigeo²

Affiliation:

1. Department of Urology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan

2. Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo 113-8421, Japan

3. D Clinic Tokyo, Tokyo 100-6210, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/70/9/70_EJ23-0078/_pdf

Reference28 articles.

1. 1 Tsujimura A, Hiramatsu I, Aoki Y, Shimoyama H, Mizuno T, et al. (2017) Atherosclerosis is associated with erectile function and lower urinary tract symptoms, especially nocturia, in middle-aged men. Prostate Int 5: 65–69.

2. 2 Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, et al. (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 159: 507–514.

3. 3 Araujo AB, Esche GR, Kupelian V, O’Donnell AB, Travison TG, et al. (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92: 4241–4247.

4. 4 Bondy CA (2006) Endogenous sex hormones and type 2 diabetes risk. JAMA 296: 169.

5. 5 Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, et al. (2003) Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci U S A 100: 9416–9421.